Lv66
2114 积分 2024-08-07 加入
Shaping the Breast in Aesthetic and Reconstructive Breast Surgery: An Easy Three-Step Principle
21分钟前
待确认
Patterns of breast reconstruction and the influence of a surgical multidisciplinary clinic
3天前
已完结
Ultrasound‐guided fine‐needle aspiration of axillary lymph nodes in breast cancer: Diagnostic accuracy and role in surgical management
7天前
已完结
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study
20天前
已完结
KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus Chemotherapy
20天前
已完结
MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study
20天前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
29天前
已完结
Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 Trial
30天前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
30天前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
30天前
已完结
急性骨筋膜室综合征早期诊断与治疗指南
8个月前
已采纳
针灸改善子宫内膜容受性有效性Meta分析
8个月前
已采纳
巨噬细胞炎症因子-1β在胶原诱导关节炎中的表达及其意义
9个月前
已采纳
成人非囊性纤维化性支气管扩张的诊治进展
9个月前
已采纳
脾脏血管肉瘤伴肝脏多发转移一例
9个月前
已采纳
皖公网安备34019202002308
